The Board of Overseers is an advisory body committed to providing counsel and support to the ADDF Board of Governors and staff. Overseers lend their expertise to advance the ADDF's mission to accelerate the discovery of drugs to prevent, treat and cure Alzheimer’s disease. Overseers are appointed by and serve at the pleasure of the Board of Governors.

Chair

Christopher Johnson

President, Rackson Companies

Bal Agrawal

Founder and Chief Executive Officer, LifeWorx, Inc.; Founder and Chief Executive Officer, Prima Chefs, Inc.

Charles Cangro

Former Principal, Personal Financial Services, Ernst & Young, LLP

Charlie Lefkowitz Crowley

Educational Consultant and Philanthropist

Mitchell D. Eichen, J.D., LL.M.

Founder and Chief Executive Officer, Acertus Capital Management
Founder and Chief Executive Officer, The MDE Group

Joel Florin

President, Micro Essential Laboratory, Inc.

Dave Gerson

Personal Financial Planning Consultant, Retired Tax Partner Ernst & Young, LLC

Stephanie Ginsberg

Volunteer, Philanthropist; Founder, BCRF Pink Promises Benefit

Allan M. Green, MD, PhD, JD

Allan M. Green Esq., LLC

Gina F. Holzheimer

Vice President, J.P. Morgan Private Bank; Co-Founder and Co-Chair, ADDF Young Professionals Committee

Mitchell Kaneff

Chairman and Chief Executive Officer, Arkay

Josh Lauder

Co-Founder and Co-Chair, ADDF Young Professionals Committee

Elise Gelman Lefkowitz

Philanthropist

Philip Lovett

Founding Partner, Millennium Partners

Julie Medler

Managing Director, Golden Seeds

Justin Meltzer

Real Estate Operations, DLA Piper LLP

Phebe Farrow Port

Senior Vice President, Global Management Strategies and Chief of Staff, Executive Management Initiatives, The Estée Lauder Companies Inc.

Gregory A. Rosica

Partner, Tax, Ernst & Young, LLC

Tom Scanlan

Partner, Spencer Stuart

John H. Scully, CIMA

Senior Managing Director, Head of Private Wealth Advisory, Nuveen Investments

Stephen Toma

Managing Director, VJMS, LLC

Wendy L. Wilshin

Founder and Principal, WLW Designs